Patent intelligence · US
US 11116733
Topical dapsone and dapsone/adaplene compositions and methods for use thereof
Topical dapsone and dapsone/adaplene compositions and methods for use thereof
Patent details — US 11116733
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 14, 2021
- Expiration
- Sep 9, 2041
- Applicant
- ALMIRALL, LLC
- Claims
- 14
- CPC classes
- A61K, A61K31/136, A61K31/145, A61K31/192
Quick answer
US 11116733 (Topical dapsone and dapsone/adaplene compositions and methods for use thereof) is held by ALMIRALL, LLC. Status: granted. Granted Sep 14, 2021. Expires Sep 9, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALMIRALL, LLC
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K31/136, A61K31/145, A61K31/192, A61K47/10, A61K47/14
More from ALMIRALL, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted -
US 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
US 12414911
Topical compositions and methods of use
granted -
US 12412764
Substrate-accommodating container
granted -
US 12398154
Azaquinazoline pan-KRas inhibitors
granted -
US 12383503
Adagrasib solid pharmaceutical compositions
granted -
US 12377101
Combination therapies
granted -
US 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted
Frequently asked questions
What is US patent 11116733?
US 11116733 (Topical dapsone and dapsone/adaplene compositions and methods for use thereof) is held by ALMIRALL, LLC. Status: granted. Granted Sep 14, 2021. Expires Sep 9, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11116733?
ALMIRALL, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 308 pharmaceutical patents for this assignee.
When does US 11116733 expire?
Our index shows an expiration date of Sep 9, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.